Skip to playerSkip to main contentSkip to footer
  • 11/9/2020
Biogen stock plunges more than 30% after a Food and Drug Administration panel committee rules against giving the company's Alzheimer's drug the nod.

Recommended

0:59
Up next
Minecraft crushes expectations at the box office
The Street
0:55
‘Minecraft’ has stellar opening weekend
The Street
0:47
An iconic sports car is getting an electric makeover - kind of
The Street
0:52
The Corvette like you’ve never seen it before
The Street
1:52
Avoid these common cruise port and excursion mistakes
The Street
1:30
FDA approves new Alzheimer’s drug from Eli Lilly
The Street
0:43
FDA Approves First Drug to Target Genetic Cause of ALS
Benzinga
0:39
FDA Approves Eli Lilly's Alzheimer's Drug, Slowing the Progression of the Brain-Wasting Disease
Benzinga
10:41
Novel Therapy Shows Promising Results In On-Going Trials, Receives 3 Orphan Drug Designations From The FDA
Benzinga
1:00
Medical advancements: New drug found to slow decline of Alzheimer’s by 35% in trial
Local TV
16:00
This Biotech Just Cleared A Big FDA Hurdle In Its Quest To Improve ADHD Treatment
Benzinga
0:48
Biogen Alzheimer's drug closer to approval
PDA Media
3:50
Landmark trial shows new drug can slow Alzheimer’s disease
ABC NEWS (Australia)
2:24
Biggest Pharmaceuticals Mergers And Acquisition in History
The Street
5:04
Families impacted by Alzheimer's express concerns over new drug Leqembi
23ABC News
0:42
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks
Benzinga
1:58
Dementia At the End of Life: What are the medications?
Healthfeedspanish
0:48
New drug breakthrough gives hope for those with Alzheimer's
ODN
1:00
Alzheimer's: New drug dubbed 'beginning of the end' in search for treatment
National World - LocalTV
1:49
Drug trial shows treatment slows progress of disease
ABC NEWS (Australia)
2:48
Mexican Billionaire Carlos Slim Is Biggest Winner Amid Tariff Rout
Forbes
1:29
Trump’s Truth Social Stake Drops $260 Million As Tariffs Shake Markets
Forbes
4:54
The Founder Of Chipotle Is Now A Billionaire
Forbes
0:35
Apple Making iPhones In America A Fantasy That Sounds Great 'Behind The Microphones,' Says Top Analyst Dan Ives
Benzinga
0:36
Bitcoin Could Test $70K Amid Fears Of 'Black Monday' Panic, Says Analyst Van de Poppe, As Global Markets Slide On Trump Tariff Shock
Benzinga